Study Team Sample Clauses

Study Team any trained and instructed person who conducts the Study under the supervision of the Investigator.
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Study Team. (a) Before the Commencement Date, the Parties shall store in the trial master file a short curriculum vitae and relevant references of the key members of the Study Team. The Parties shall not remove or replace any key member of their Study Team without the Sponsor’s prior written approval (which approval the Sponsor shall not unreasonably withhold or delay), unless the person has left the employ of the relevant Party. If, in the Sponsor’s reasonable opinion, a key member of a Study Team is not able to perform its duties in accordance with this Agreement, the Sponsor shall have the right to request the relevant Party to replace such person and the Sponsor and the relevant Party shall meet and discuss to find a reasonable solution. In any case, the Parties shall at all times ensure that they have appropriate replacement immediately available for each key member of their Study Team in the event such key member leaves the employ of said Party; this replacement shall be organized in such a way that a key member leaving the employ of said Party has no negative impact on the performance of the Clinical Study or on the safety of the patients.
Sample 1Sample 2
Study Team. The feasibility study was carried out using suitably qualified external consultants where appropriate and included: • Resource Estimate – Xxxxx Geological Services • Resource Optimisation and Open Pit Design – MineComp Kalgoorlie • Geotechnical – Green Geotechnical • Metallurgy – ALS Metallurgy supervised by Minelogix • Environmental (Mine Plan and Closure Plan) – Botanica • Hydrogeological (surface and ground) Review - Groundwater Resource Management Open Pit Mining Open pit mining will be by conventional truck and excavator with the pit to be mined to a maximum depth of 60m. A two stage grade control program will be completed with an initial program commencing at surface prior to mining commencing.
Sample 1
Study Team. The PI designates study team members. The Study Team typically includes but is not limited to the following roles, with some individuals fulfilling more than one role:  Principal Investigators (PI) or multiple PIs  Co-investigators or Investigator  Project Director (PD)  Biostatistician  Programmer/Analyst  Research NurseResearch Assistant (RA)  Research Coordinator (RC)  Ancillary personnel may also play a role but may not be considered ‘team’ members.  All members of the study team must comply with relevant HSL and Marcus Institute procedures, policies and guidelines.  Study team members will provide documentation of current human subjects’ research training, professional credentials, and licensure (if required for their role in the study). CITI training (xxxxx://xxxxx.xxxxxxxxxxx.xxx/en/homepage/) is available for all study team members who are new to their roles or who would like a refresher.  Additional study specific training will be completed by team members who have been delegated to perform activities requiring it, such as use of study specific equipment.  Up-to-date documentation of all training will be kept in the Regulatory Binder (see below).
Sample 1
Study Team. The study team consisted of eight members: the author; two public health students with considerable field experience from the École Nationale de la Santé Publique (National Public Health School) in Zinder; a trained and currently active trichiasis surgeon employed by the Ministry of Health; a Xxxxxx Center Niger staff member trained as a Technicien Superieur en Ophthalmologie (Superior Technician in Ophthalmology) ; and three transcriptionists from the Direction Régionale de la Santé Publique (Regional Directorate of Public Health). All study team members were fluent in French and familiar with the local culture, and all except the author were fluent in Hausa, the language in which the study was to be conducted.
Sample 1
Study Team. Institution may appoint sub-investigators and other personnel as it may deem appropriate to assist in the conduct of the Study (“Study Personnel”). Clinical Trial Agreement
Sample 1
Study Team. Teva shall establish the Study Team in consultation with the Company. The function of the Study Team shall be to manage and monitor the Trial in accordance with Appendix A and the terms of this Agreement.
Sample 1
AutoNDA by SimpleDocs
Study Team. The ESIA Study was conducted by the following Experts:
Sample 1

Related to Study Team

  • Project Team To accomplish Owner’s objectives, Owner intends to employ a team concept in connection with the construction of the Project. The basic roles and general responsibilities of team members are set forth in general terms below but are more fully set forth in the Design Professional Contract with respect to the Design Professional, in the Program Management Agreement with any Program Manager, and in this Contract with respect to the Contractor.

  • Research Committee 2.2.1 Establishment and Functions of RC. ---------------------------------

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Steering Committee The Project Manager shall set up a Steering Committee for the Project, consisting of representatives from the Department, the Contractor, and any other key organisations whom the project will impact on, to be agreed between the parties. The function of the Steering Committee shall be to review the scope and direction of the Project against its aims and objectives, monitor progress and efficiency, and assess, manage and review expected impact and use of the findings from the Project. The Committee shall meet at times and dates agreed by the parties, or in the absence of agreement, specified by the Department. The Contractor’s representatives on the Steering Committee shall report their views on the progress of the Project to the Steering Committee in writing if requested by the Department. The Contractor’s representatives on the Steering Committee shall attend all meetings of the Steering Committee unless otherwise agreed by the Department.

  • Joint Project Team As soon as possible after the Effective Date, the Parties shall establish a joint project team (the “JPT”) which shall be initially responsible for the day-to-day operations of the Initial Target Program. The JPT shall also be responsible for the day-to-day operations of all other Collaboration Programs when they become ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. effective; provided, that if multiple JPTs are needed due to different Targets or disease areas, then the Parties may establish separate JPTs for different Collaboration Programs. The JPT shall be comprised of representatives from each of GSK and Adaptimmune with the appropriate scientific expertise with respect to the conduct of the Development Plans (and such representatives may vary depending on the relevant Project Phase) and shall meet on a monthly basis (or more or less frequently as agreed by the Parties) at Adaptimmune’s facilities, GSK’s facilities or via teleconference at such times as may be agreed by the Parties during the term of the applicable Collaboration Program. The JPT will report to the JSC and will be responsible for the day-to-day management of the conduct of the Development Plans including any non-material changes to the Development Plans, overseeing the conduct of experiments and reviewing data resulting from such experiments as set forth in the Development Plans, proposing amendments to the Development Plans, proposing new Development Plans to the JSC for new Collaboration Programs for JSC approval, discussing potential Lead Candidates and Development Candidates for proposal to the JSC. All decisions of the JPT on matters for which it has responsibility shall be made unanimously. In the event that the JPT is unable to reach a unanimous decision within ten (10) Business Days after it has met and attempted to reach such decision, then either Party may, by written notice to the other, have such issue submitted to the JSC for resolution in accordance with Section 4.5. Each Party will bear all expenses it incurs in regard to participating in all meetings of the JPT, including all travel and living expenses. Each JPT shall automatically cease to exist on completion of the relevant Collaboration Programs that it supports and exercise or expiry of all Collaboration Program Options applicable to such Collaboration Programs.

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Joint Steering Committee [***] following the Effective Date [***], a joint steering committee (the “JSC”) will be established by the Parties to provide oversight and to facilitate information sharing between the Parties with respect to the activities under this Agreement.

  • Project Managers The JBE’s project manager is: [Insert name]. The JBE may change its project manager at any time upon notice to Contractor without need for an amendment to this Agreement. Contractor’s project manager is: [Insert name]. Subject to written approval by the JBE, Contractor may change its project manager without need for an amendment to this Agreement.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Principal Investigator The research will be under the direction of (“Principal Investigator”). If, for any reason, he/she is unable to continue to serve as Principal Investigator and a successor acceptable to both UHD and Sponsor is not available, this Agreement shall be terminated as provided in Section 7.

Time is Money Join Law Insider Premium to draft better contracts faster.